Business Context and Reporting Period
This Form 8-K Current Report was filed by Conversion Labs, Inc. (trading symbol: CVLB) on January 14, 2021, covering events occurring on January 8, 2021. The filing details the results of a Special Meeting of Shareholders and the approval of the company's 2020 Equity Incentive Plan. Note: The request metadata references "Lifemd, Inc.," but the source document explicitly identifies the registrant as Conversion Labs, Inc.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The document does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Shareholder Actions
On January 8, 2021, the Company held a Special Meeting of Shareholders. As of the record date, there were 20,992,373 shares of common stock outstanding. Shares representing 53.53% of the total voting power were present by proxy. Three proposals were voted upon:
- Proposal 1 (Approved): Approval of the 2020 Equity Incentive Plan, authorizing the issuance of up to 1,500,000 shares of common stock for employee and director compensation.
- Proposal 2 (Approved): Ratification of the Series B Convertible Preferred Stock actions, including the amendment to the Certificate of Incorporation and the issuance of 3,500 shares of Series B Convertible Preferred Stock.
- Proposal 3 (Approved): Ratification of potential adjournments to solicit additional proxies (not utilized as sufficient votes were obtained).
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies. The primary focus is the administrative approval of the equity plan and the ratification of prior capital structure changes.
Investor Verification Checklist
- Verify the full text of the 2020 Equity Incentive Plan (Exhibit 4.1) to understand vesting schedules and dilution potential.
- Review the Series B Convertible Preferred Stock terms to understand conversion rights and seniority relative to common stock.
- Confirm the Proxy Statement filed on December 7, 2020, for detailed background on the proposals.
- Check subsequent filings for the actual issuance of shares under the new 2020 Plan.